WHO ICTRP trial
APO866 for B-Cell Leukaemia. An open phase I/II clinical study assessing the…
EUCTR2006-002850-31-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-002850-31-GB |
|---|---|
| Public title | APO866 for B-Cell Leukaemia. An open phase I/II clinical study assessing the safety and tolerability of APO866 in patients with refractory B-cell lymphocytic leukaemia not amenable to allogeneic hemopoietic stem cell transplantation |
| Scientific title | APO866 for B-Cell Leukaemia. An open phase I/II clinical study assessing the safety and tolerability of APO866 in patients with refractory B-cell lymphocytic leukaemia not amenable to allogeneic hemopoietic stem cell transplantation |
| Primary sponsor | TopoTarget A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | The medical condition for this clinical trial is B. cell chronic lymphocytic leukemia. MedDRA version: 8.1 Level: LLT Classification code 10003894 Term: B-cell chronic lymphocytic leukaemia/prolymphocytic leukaemia/small lymphocytic… |
| Interventions | Product Name: N-[4-(benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)acrylamide Product Code: APO866 Pharmaceutical Form: Solution for injection INN or Proposed INN: N-[4-(benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)acrylamide Concentration… |
| Registration date | Sep 20, 2006 |
| Target size | 10 |
| Secondary IDs | AP3005 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: